Bo Ke Selected Research

Cyclodextrins

4/2014

Star-shaped cyclodextrin-poly(l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Ke Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 04/2014
2	Multiple Myeloma 01/2023 - 01/2022
2	Hemolysis 04/2016 - 04/2014
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2016 - 04/2014
1	Inflammation (Inflammations) 01/2023
1	Leukemia 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2019
1	Hemorrhage 04/2019
1	Intervertebral Disc Displacement (Herniated Disc) 01/2019
1	Intervertebral Disc Degeneration 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Communicable Diseases (Infectious Diseases) 10/2014
1	Nasopharyngeal Carcinoma 03/2014

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
2	Docetaxel (Taxotere)FDA Link 04/2016 - 04/2014
1	CytokinesIBA 01/2023
1	Long Noncoding RNAIBA 01/2022
1	olaparibIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	IronIBA 01/2022
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2022
1	AnthracyclinesIBA 01/2022
1	Interleukin-11 (Interleukin 11)IBA 04/2019
1	Inosine Triphosphate (ITP)IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 04/2016
1	Dosage Forms (Dosage Form)IBA 10/2014
1	polyethylene glycol polyethyleneimine nanogelIBA 10/2014
1	polymethacrylic acid (PMAA)IBA 10/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	Lysine (L-Lysine)FDA Link 04/2014
1	CyclodextrinsIBA 04/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2014
1	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 03/2014

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2014